Ads
related to: novavax vaccine
Search results
Novavax’s R&D head, integral to Covid vaccine work, to retire - Washington Business Journal
The Business Journals· 22 hours agoThe head of research and development at Novavax Inc., a key player in the development of its...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 6 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 7 days agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
Researchers are developing an experimental bird flu mRNA vaccine
Quartz· 2 days agoResearchers are developing an mRNA-based vaccine against the contagious H5N1 bird flu virus that is...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 6 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks via Yahoo Finance· 2 days agoZacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 6 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 2 days agoThe three vaccines updated to target the SARS-CoV-2 XBB.1.5 subvariant -- Moderna's and Pfizer-BioNTech's mRNA vaccines and the Novavax
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) shot up 3.4% during trading on Wednesday . 1,132,956 shares changed hands during trading, a decline of 90% from the average session ...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 1 day agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...